We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Concerns About Living Donor Liver Transplants

By HospiMedica staff writers
Posted on 02 Jul 2001
According to an article published in The New England Journal of Medicine , adult liver transplants using livers from living donors is a practice that has spread too widely and too quickly. More...
Many transplant centers are performing the procedure without the experience and skills needed and with no oversight, say the authors, Drs. David C. Cronin II, J. Michael Millis, and Mark Siegler, all from the University of Chicago (IL, USA).

Using livers from living donors was begun in 1995. Since 1997, more than 30 U.S. programs have performed more than 400 such procedures. Six programs performed only one, while one program has performed more than 100. As a sign of the practice's popularity, 23 centers are planning to initiate the practice. Unlike living donor liver transplants in children, many aspects of the practice in adults remain unformulated. These include a lack of agreement on the best and safest technique, a lack of standardized indications for surgery, and a lack of unvarying standards for institutional review.

The authors believe that the practice should be restricted to high-volume transplantation centers that are very experienced in the procedure. Data should be collected on short- and long-term outcomes. The authors are also concerned that donor deaths are not being reported accurately and that proper informed consent of both donors and recipients is not always acquired. To help solve these problems, they believe oversight should be provided by health insurers and government agencies.




Related Links:
New England Journal of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.